Large-scale testing (Phase 3)Ended earlyNCT00630487What this trial is testingEfficacy of Somatropin in Adult Patients With Isolated Growth Hormone DeficiencyWho this might be right forGrowth Hormone Deficiency Pfizer 9
Post-approval studies (Phase 4)Study completedNCT02726009What this trial is testingA Trial to Evaluate Safety of Firmagon® (Degarelix) in Indian Patients Diagnosed With Advanced Hormone-dependent Prostate CancerWho this might be right forProstate Cancer Ferring Pharmaceuticals 230
Not applicableStudy completedNCT06498921What this trial is testingAn Observational Study to Learn More About the Use of Darolutamide as a Part of a Combination Therapy in Belgian Men With Metastatic Hormone-Sensitive Prostate Cancer in Routine Medical CareWho this might be right forMetastatic Hormone-sensitive Prostate Cancer Bayer 106
Not applicableStudy completedNCT03401034What this trial is testingInfluence of Lifestyle, Inflammatory Biomarkers, and Genetic Factors on Long-term Breast Cancer PrognosisWho this might be right forBreast CancerBreast Cancer MortalityBreast Cancer Survival+7 more German Cancer Research Center 3,813
Not applicableUnknownNCT04116827What this trial is testingSleep and Activity Patterns in Pre-menopausal Breast Cancer Patients on Tamoxifen Using a Wrist-worn Internet of Things DeviceWho this might be right forSleep DisorderBreast Cancer Samsung Medical Center 20
Testing effectiveness (Phase 2)Study completedNCT02616562What this trial is testingInvestigating Efficacy and Safety of Once-weekly NNC0195-0092 Treatment Compared to Daily Growth Hormone Treatment (Norditropin® FlexPro®) in Growth Hormone Treatment naïve Pre-pubertal Children With Growth Hormone DeficiencyWho this might be right forGrowth Hormone DisorderGrowth Hormone Deficiency in Children Novo Nordisk A/S 76
Large-scale testing (Phase 3)Looking for participantsNCT05646862What this trial is testingA Study Evaluating the Efficacy and Safety of Inavolisib Plus Fulvestrant Compared With Alpelisib Plus Fulvestrant in Participants With HR-Positive, HER2-Negative, PIK3CA Mutated, Locally Advanced or Metastatic Breast Cancer Post CDK4/6i and Endocrine Combination TherapyWho this might be right forBreast Cancer Hoffmann-La Roche 420
Not applicableStudy completedNCT00784888What this trial is testingResearch Of Quality Of Life And Safety Outcomes Of Postmenopausal Breast Cancer Patients Switching From Tamoxifen Therapy To Aromatase Inhibitor TherapyWho this might be right forBreast Neoplasms Pfizer 344
Post-approval studies (Phase 4)Study completedNCT01553903What this trial is testingFeasibility Study for the Determination of Oxysterols in Patients With Breast Cancer Receiving Hormonal Therapy With Tamoxifen or NotWho this might be right forBreast Cancer Institut Claudius Regaud 29
Large-scale testing (Phase 3)Ended earlyNCT04409288What this trial is testingPatient Preference of Apalutamide Versus Enzalutamide in Patients With Recurrent or Metastatic Hormone-Sensitive Prostate CancerWho this might be right forProstate Cancer Chinese University of Hong Kong 74
Post-approval studies (Phase 4)Looking for participantsNCT06834594What this trial is testingBleeding Patterns in Sequential and Continuous Progesterone Supplementation in Adolescents With Turner SyndromeWho this might be right forTurner SyndromePrimary Ovarian Insufficiency (Poi) Children's Mercy Hospital Kansas City 40
Early research (Phase 1)Study completedNCT01248494What this trial is testingPhIb BKM120 or BEZ235+Endocrine Treatment in Post-Menopausal Patients With Hormone Receptor + Metastatic Breast CancerWho this might be right forMetastatic Breast Cancer Vanderbilt-Ingram Cancer Center 72
Not applicableStudy completedNCT07428642What this trial is testingPSMA PET/CT-Based Multimodal Model for Predicting Response to First-Line Therapy in mHSPC.Who this might be right forMetastatic Hormone-Sensitive Prostate CancerProstate Cancer First Affiliated Hospital of Wenzhou Medical University 168
Testing effectiveness (Phase 2)Study completedNCT00990886What this trial is testingThe Effect of Extended-Release Oxybutynin Chloride on Vasomotor Symptoms in Healthy Post-Menopausal WomenWho this might be right forMenopauseHot Flashes Ortho-McNeil Janssen Scientific Affairs, LLC 148
Not applicableUnknownNCT04079270What this trial is testingThe Breast Cancer Personalized Nutrition StudyWho this might be right forBreast Cancer Sheba Medical Center 200
Not applicableStudy completedNCT02015286What this trial is testingTo Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Middle EastWho this might be right forGrowth Disorders Merck KGaA, Darmstadt, Germany 7
Not applicableStudy completedNCT02850939What this trial is testingImproving Adherence to EHT Among Breast Cancer PatientsWho this might be right forBreast Cancer The University of Texas Health Science Center at San Antonio 108
Testing effectiveness (Phase 2)Study completedNCT03054363What this trial is testingTucatinib, Palbociclib and Letrozole in Metastatic Hormone Receptor Positive and HER2-positive Breast CancerWho this might be right forBreast Cancer University of Colorado, Denver 42
Not applicableUnknownNCT00187993What this trial is testingGrowth Hormone Treatment of Young Growth Hormone-Deficient AdultsWho this might be right forGrowth Hormone Deficiency University Hospital, Angers 30
Testing effectiveness (Phase 2)Study completedNCT06375707What this trial is testingFirst-Line Ribociclib Plus Endocrine Therapy Versus Chemotherapy With or Without Subsequent Endocrine Therapy in Patients With Rapidly Progressive HR-Positive/HER2-Negative Advanced Breast CancerWho this might be right forAdvanced Breast Cancer The First Affiliated Hospital with Nanjing Medical University 74